Skip to main content

Table 2 Genotypic and allelic frequencies of 14 tag-SNPs in the RCC cases and controls

From: Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population

  P1a OR (95% CI)a P2a HWE
VEGF
 rs2010963 0.775 1.16 (0.77–1.73) 0.47 0.51
 rs699947 0.416 1.31 (0.87–1.95) 0.21 0.91
 rs833061 0.475 1.27 (0.85–1.89) 0.26 0.96
VHL
 rs1642742 0.663 0.88 (0.59–1.31) 0.61 0.82
 rs779805 0.691 0.88 (0.59–1.32) 0.61 0.88
FAF1
 rs4381241 0.417 1.27 (0.85–1.89) 0.26 0.40
 rs67311347 0.086 1.49 (0.99–2.25) 0.05 0.20
LRRIQ4
 rs10936602 0.248 0.69 (0.39–1.20) 0.21 0.70
RHOBTB2
 rs2241261 0.604 0.89 (0.60–1.33) 0.61 0.91
OBFC1
 rs11813268 0.869 0.89 (0.59–1.34) 0.60 0.07
ATM
 rs1800057 0.034 10.93 (1.35–88.31) 0.01 0.53
DPF3
 rs49030664 0.979 1.04 (0.69–1.55) 0.91 0.93
ALDH9A1
 rs3845536 0.015 0.62 (0.41–0.93) 0.02 0.76
EPAS1
 rs7579899 0.977 1.02 (0.69–1.52) 0.91 0.64
  1. aχ2 test or Fisher’s exact test. P1: Genotypic frequencies p value. P2: Allelic frequencies p value. OR: Odds Ratio. CI: Confidence Interval